ALLR Allarity Therapeutics Inc.: Enterprise Value-to-Revenue Multiple

Allarity (ALLR) - corporate logo

The key growth driver for Allarity Therapeutics (ALLR) is the development of personalized drugs via the DRP system, which shapes the business value-to-revenue dynamics. The value of 36485.71 reflects this status. Revenues are projected to stem from insurance payouts for the treatment of complex pathologies. Furthermore, the business relies on complete independence from economic cycles and macroeconomic shocks.

ALLR: Allarity Therapeutics, Inc. EV/Sales Multiple 11/23/2025 - 11/20/2026

ALLR (allarity.com): analytical breakdowns and indicator data

- cash and cash flow indicators:
Initial company analysis:ALLR, Allarity Therapeutics Inc.
Core merchandise of Allarity Therapeutics

This indicator determines the enterprise value of the business, including debt and excluding cash, relative to sales volume, allowing for an assessment of revenue generation efficiency without the influence of debt load. By analyzing the business valuation via EV/Sales, an investor will see how inflated the expectations for stenoparib are against a backdrop of critical liquidity shortages and the acute need for working capital at Allarity Therapeutics (ALLR).